NCT02036645 SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. Status COMPLETED Phase PHASE1
NCT02032823 Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02031679 Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines Status COMPLETED Phase PHASE2
NCT02028507 Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors Status COMPLETED Phase PHASE3
NCT02024477 Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients Status COMPLETED Phase PHASE4
NCT02022748 Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects Status COMPLETED Phase PHASE1
NCT02022007 Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis Status COMPLETED Phase PHASE3
NCT02015624 EYESHOT (EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian Coronary Care Units) Status COMPLETED Phase N/A
NCT02010970 A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate Status COMPLETED Phase PHASE1
NCT02009865 Epanova® for Lowering Very High Triglycerides II (EVOLVE II) Status COMPLETED Phase PHASE3
NCT02005211 A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers Status COMPLETED Phase PHASE1
NCT02001545 REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients Status COMPLETED Phase N/A
NCT02000622 Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. Status COMPLETED Phase PHASE3
NCT02000193 Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT01997450 A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age Status TERMINATED Phase N/A